The deadly fungus Candidozyma Auris has spread to 72 UK hospitals in the last two years alone as medics previously warned the ...

A new study by researchers at the Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, has found that some ...

Avocados, a beloved kitchen staple, are notoriously delicate and ripen quickly. Understanding their biological nature as ...

Kerala has published the 2024 State Antibiogram (AMR Surveillance Report), presenting an assessment of antimicrobial resistance (AMR) trends and the state’s strategy to curb misuse of antibiotics. <br ...

Sanofi and Regeneron’s Dupixent (dupilumab) could be set for its ninth US approval after the drug met all the primary and secondary endpoints in a Phase III study in allergic fungal rhinosinusitis ...

ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review Phase ...

Fungi in cities are adapting to rising temperatures, a shift that could increase their chances of surviving in the human body ...

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics through its boron chemistry platform, today announced a collaboration agreement with the ...

LYL273 has demonstrated a 67% overall response rate, an 83% disease control rate, and a manageable safety profile at the ...

Research into treatment for Valley fever, a fungal disease, continues, as does work on a vaccine to prevent it.

Detailed price information for Arcutis Biotherapeutics Inc (ARQT-Q) from The Globe and Mail including charting and trades.

A pathologist died at Wythenshawe Hospital after he was given the wrong drug, causing an overdose, a coroner has said ...